Evidence map›Paper›PMID 36679715›Full record

ArticleSensors (Basel, Switzerland)2023

Paroxysmal Slow-Wave Events Are Uncommon in Parkinson's Disease.

Dan Z Milikovsky, Yotam Sharabi, Nir Giladi, Anat Mirelman, Ronen Sosnik, Firas Fahoum, Inbal Maidan

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dan Z MilikovskyDepartment of Neurology, Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.
Yotam SharabiLaboratory of Early Markers of Neurodegeneration (LEMON), Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.
Nir GiladiDepartment of Neurology, Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.ORCID 0000-0003-1482-8522
Anat MirelmanDepartment of Neurology, Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.
Ronen SosnikFaculty of Engineering, Holon Institute of Technology (HIT), Holon 5810201, Israel.ORCID 0000-0002-8582-349X
Firas FahoumDepartment of Neurology, Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.ORCID 0000-0003-2262-5530
Inbal MaidanDepartment of Neurology, Neurological Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.ORCID 0000-0001-7370-5798
Tel Aviv University · ILHolon Institute of Technology · IL

Funding

Israel Science Foundation 1157/20Orion program Orion program
6 · The paper itself

Abstract

Background: Parkinson’s disease (PD) is currently considered to be a multisystem neurodegenerative disease that involves cognitive alterations. EEG slowing has been associated with cognitive decline in various neurological diseases, such as PD, Alzheimer’s disease (AD), and epilepsy, indicating cortical involvement. A novel method revealed that this EEG slowing is composed of paroxysmal slow-wave events (PSWE) in AD and epilepsy, but in PD it has not been tested yet. Therefore, this study aimed to examine the presence of PSWE in PD as a biomarker for cortical involvement. Methods: 31 PD patients, 28 healthy controls, and 18 juvenile myoclonic epilepsy (JME) patients (served as positive control), underwent four minutes of resting-state EEG. Spectral analyses were performed to identify PSWEs in nine brain regions. Mixed-model analysis was used to compare between groups and brain regions. The correlation between PSWEs and PD duration was examined using Spearman’s test. Results: No significant differences in the number of PSWEs were observed between PD patients and controls (p > 0.478) in all brain regions. In contrast, JME patients showed a higher number of PSWEs than healthy controls in specific brain regions (p < 0.023). Specifically in the PD group, we found that a higher number of PSWEs correlated with longer disease duration. Conclusions: This study is the first to examine the temporal characteristics of EEG slowing in PD by measuring the occurrence of PSWEs. Our findings indicate that PD patients who are cognitively intact do not have electrographic manifestations of cortical involvement. However, the correlation between PSWEs and disease duration may support future studies of repeated EEG recordings along the disease course to detect early signs of cortical involvement in PD.

Indexed as

Alzheimer DiseaseMyoclonic Epilepsy, JuvenileNeurodegenerative DiseasesParkinson DiseaseBrainElectroencephalographyHumansbiomarkerEEGepilepsyParkinson’s diseaseparoxysmal slow-wave events

Identifiers

PMID36679715
PMCPMC9862294
OpenAlexW4316039231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.